| Original language | English (US) |
|---|---|
| Pages (from-to) | 899-900 |
| Number of pages | 2 |
| Journal | JAMA - Journal of the American Medical Association |
| Volume | 324 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 1 2020 |
Bibliographical note
Funding Information:Conflict of Interest Disclosures: Dr Lin reported receiving grants from the National Institute of Diabetes and Digestive and Kidney Diseases and personal
Funding Information:
Gilead, Intercept, Conatus, and Genfit. Dr Ikramuddin reported receiving grant support from ReShape Life Sciences and equipment from Medtronic. No other disclosures were reported.